JP2017516066A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017516066A5 JP2017516066A5 JP2016549735A JP2016549735A JP2017516066A5 JP 2017516066 A5 JP2017516066 A5 JP 2017516066A5 JP 2016549735 A JP2016549735 A JP 2016549735A JP 2016549735 A JP2016549735 A JP 2016549735A JP 2017516066 A5 JP2017516066 A5 JP 2017516066A5
- Authority
- JP
- Japan
- Prior art keywords
- shpt
- patient
- risk factor
- receiving
- determining
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 208000005770 Secondary Hyperparathyroidism Diseases 0.000 claims 44
- 238000012502 risk assessment Methods 0.000 claims 19
- 108090000445 Parathyroid hormone Proteins 0.000 claims 10
- 238000000034 method Methods 0.000 claims 10
- 230000013878 renal filtration Effects 0.000 claims 8
- 230000004044 response Effects 0.000 claims 8
- 102000003982 Parathyroid hormone Human genes 0.000 claims 6
- 230000024924 glomerular filtration Effects 0.000 claims 6
- 239000000199 parathyroid hormone Substances 0.000 claims 6
- 229960001319 parathyroid hormone Drugs 0.000 claims 6
- 239000003550 marker Substances 0.000 claims 5
- 102100036893 Parathyroid hormone Human genes 0.000 claims 4
- 206010012601 diabetes mellitus Diseases 0.000 claims 3
- 108060006698 EGF receptor Proteins 0.000 claims 2
- UXIGWFXRQKWHHA-UHFFFAOYSA-N Iotalamic acid Chemical compound CNC(=O)C1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I UXIGWFXRQKWHHA-UHFFFAOYSA-N 0.000 claims 2
- 238000004364 calculation method Methods 0.000 claims 2
- 229960000929 iotalamic acid Drugs 0.000 claims 2
- 238000004088 simulation Methods 0.000 claims 2
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461935593P | 2014-02-04 | 2014-02-04 | |
| US61/935,593 | 2014-02-04 | ||
| US14/612,109 US20150220698A1 (en) | 2014-02-04 | 2015-02-02 | Systems and methods for determining secondary hyperparathyroidism risk factors |
| US14/612,109 | 2015-02-02 | ||
| PCT/US2015/014188 WO2015119915A1 (en) | 2014-02-04 | 2015-02-03 | Systems and methods for determining secondary hyperparathyroidism risk factors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017516066A JP2017516066A (ja) | 2017-06-15 |
| JP2017516066A5 true JP2017516066A5 (enExample) | 2018-03-01 |
Family
ID=53755064
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016549735A Withdrawn JP2017516066A (ja) | 2014-02-04 | 2015-02-03 | 二次性副甲状腺機能亢進症のリスク因子を決定するためのシステムおよび方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20150220698A1 (enExample) |
| EP (1) | EP3102952A1 (enExample) |
| JP (1) | JP2017516066A (enExample) |
| HK (1) | HK1231557A1 (enExample) |
| WO (1) | WO2015119915A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10796802B1 (en) | 2015-05-01 | 2020-10-06 | Cerner Innovations, Inc. | Computer decision support for determining surgery candidacy in stage four chronic kidney disease |
| US10600067B2 (en) * | 2016-06-16 | 2020-03-24 | Accenture Global Solutions Limited | Demographic based adjustment of data processing decision results |
| CN117577321A (zh) * | 2017-08-08 | 2024-02-20 | 费森尤斯医疗保健控股公司 | 用于治疗和评估慢性肾脏疾病的进程的系统和方法 |
| US11238989B2 (en) * | 2017-11-08 | 2022-02-01 | International Business Machines Corporation | Personalized risk prediction based on intrinsic and extrinsic factors |
| EP4115815A4 (en) * | 2020-03-27 | 2023-08-09 | TERUMO Kabushiki Kaisha | Biological function estimation device and biological function estimation method |
| JP6948497B1 (ja) * | 2020-06-05 | 2021-10-13 | 株式会社コスミックコーポレーション | 生体情報評価システム及び生体情報評価プログラム |
| KR20240029727A (ko) * | 2021-07-29 | 2024-03-06 | 주식회사 타이로스코프 | 대상에 대한 갑상선기능이상증의 예측방법 및 시스템 |
-
2015
- 2015-02-02 US US14/612,109 patent/US20150220698A1/en not_active Abandoned
- 2015-02-03 WO PCT/US2015/014188 patent/WO2015119915A1/en not_active Ceased
- 2015-02-03 HK HK17105029.5A patent/HK1231557A1/zh unknown
- 2015-02-03 JP JP2016549735A patent/JP2017516066A/ja not_active Withdrawn
- 2015-02-03 EP EP15705168.1A patent/EP3102952A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lin et al. | A simulated annealing heuristic for the multiconstraint team orienteering problem with multiple time windows | |
| Tripoliti et al. | Heart failure: diagnosis, severity estimation and prediction of adverse events through machine learning techniques | |
| CN108922129B (zh) | 一种调整安防传感器报警阈值的方法、装置、云端及系统 | |
| US9760832B2 (en) | Method and apparatus for predicting based on multi-source heterogeneous data | |
| US8751414B2 (en) | Identifying abnormalities in resource usage | |
| WO2014200655A4 (en) | Initiating background updates based on user activity | |
| JP2016517576A5 (enExample) | ||
| Curtice et al. | Modeling the spatial and temporal dynamics of foraging movements of humpback whales (Megaptera novaeangliae) in the Western Antarctic Peninsula | |
| JP2016539412A5 (enExample) | ||
| JP2017073161A5 (enExample) | ||
| JP2016517507A5 (enExample) | ||
| JP2015525487A5 (enExample) | ||
| US20160011908A1 (en) | Task allocation in a computing environment | |
| HK1231557A1 (zh) | 用於确定继发性甲状旁腺机能亢进风险因子的系统和方法 | |
| CN112105933A (zh) | 用于针对慢性肾脏疾病风险对受试者进行筛查的方法和计算机实现的方法 | |
| JP2018041442A5 (enExample) | ||
| RU2017134645A (ru) | Способ и система связывания пользователя с носимым устройством | |
| JP2018517217A5 (enExample) | ||
| WO2016112213A3 (en) | Global financial crisis prediction and geopolitical risk analyzer | |
| US11957986B2 (en) | Methods and apparatuses for dynamic determination of computer program difficulty | |
| Githeko | Advances in developing a climate based dengue outbreak models in Dhaka, Bangladesh: challenges & opportunities | |
| JP2016050868A5 (enExample) | ||
| Chase et al. | Presence of early CKD-related metabolic complications predict progression of stage 3 CKD: a case-controlled study | |
| JP2016540293A5 (enExample) | ||
| Bouguerra et al. | Applying the moving epidemic method to determine influenza epidemic and intensity thresholds using influenza‐like illness surveillance data 2009‐2018 in Tunisia |